Weekly Recap | Regeneron Pharma +1.81%, most brokers rate it buyWeekly Review·Oct 24, 2026 at 06:53 AMREGN+13.33%
Weekly Recap | Natera +2.67%, consensus target above spotWeekly Review·Oct 24, 2026 at 06:45 AMNTRA-4.98%
Weekly Recap | Gilead Sciences -0.1%, busy week in IBD pipelineWeekly Review·Oct 24, 2026 at 06:21 AMGILD+3.06%
Weekly Recap | Regeneron Pharma +5.92%, consensus target above spotWeekly Review·Oct 17, 2026 at 08:05 AMREGN+13.33%
Weekly Recap | Natera -1.81%, Signatera lands on TIME listWeekly Review·Oct 17, 2026 at 07:47 AMNTRA-4.98%
Weekly Recap | Gilead Sciences +3.32%, closing in on record highsWeekly Review·Oct 17, 2026 at 07:14 AMGILD+3.06%
Weekly Recap | Biogen +3.07%, most brokers rate it buyWeekly Review·Oct 17, 2026 at 06:39 AMBIIB+1.59%
